Head-to-head comparison of tau PET tracers [18F]PI-2620 and [18F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort

被引:0
作者
Tonietto, Matteo [1 ]
Sotolongo-Grau, Oscar [2 ]
Roe-Vellve, Nuria [3 ]
Bullich, Santiago [3 ]
Tartari, Juan Pablo [2 ]
Sanabria, Angela [2 ,4 ]
Garcia-Sanchez, Ainhoa [2 ]
Borroni, Edilio [1 ]
Galli, Christopher [1 ]
Perez-Martinez, Esther [3 ]
Castell-Conesa, Joan [5 ]
Roca, Isabel [5 ]
Tarraga, Lluis [2 ,4 ]
Ruiz, Agustin [2 ,4 ]
Stephens, Andrew W. [3 ]
Boada, Merce [2 ,4 ]
Klein, Gregory [1 ]
Marquie, Marta [2 ,4 ]
机构
[1] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Roche Pharm Res & Early Dev Neurosci & Rare Dis, Basel, Switzerland
[2] Univ Int Catalunya, Ace Alzheimer Ctr Barcelona, Barcelona, Spain
[3] Life Mol Imaging GmbH, Berlin, Germany
[4] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, CIBERNED, Madrid, Spain
[5] SIMM Imagen Med, Barcelona, Spain
关键词
Tau; Positron emission tomography; 18F]PI-2620; 18F]RO948; FACEHBI; Subjective cognitive decline; Mild cognitive impairment; Alzheimer; BIOMARKERS; RISK;
D O I
10.1186/s13195-024-01622-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundSecond-generation tau tracers for positron emission tomography (PET) show high affinity for paired helical filaments tau deposits characteristic of Alzheimer<acute accent>s disease and low off-target binding. Differences in their chemical structure though may lead to variations in their regional tau uptake and off-target signal. In this work, we aimed to compare the in-vivo uptake of tau tracers [18F]PI-2620 and [18F]RO948 in the early stages of the AD continuum.MethodsData from the TAU-PET FACEHBI clinical trial (EUDRA-CT 2021-000473-83) were analyzed. All participants were non-demented and underwent tau imaging with [18F]PI-2620 and [18F]RO948 PET within 3 months, amyloid imaging with [18F]Florbetaben and brain magnetic resonance imaging. Tau PET standardized uptake values ratios (SUVR) were calculated in Braak and typical off-target regions using the inferior cerebellar cortex as a reference region.ResultsThe cohort consisted of 18 individuals with subjective cognitive decline (n = 13) and mild cognitive impairment (n = 5), with centiloid values ranging from 17 to 159. Both tau tracers showed similar tau pathology distribution but presented a distinct off-target signal pattern on visual read. SUVR measurements for [18F]PI-2620 and [18F]RO948 were highly correlated in all Braak regions (R2 range [0.65-0.80]). Regarding off-target signal, [18F]PI-2620 had higher SUVRs in vascular structures, and [18F]RO948 had higher SUVRs in the skull/meninges.ConclusionsIn a cohort of individuals at early stages of the AD continuum, tau PET tracers [18F]PI-2620 and [18F]RO948 showed similar in-vivo uptake in all Braak regions and distinct off-target signal. These preliminary results support the development of standardized quantification scales for tau deposition that are tracer-independent.Trial registrationAEMPS EudraCT 2021-000473-83. Registered 30 December 2021.
引用
收藏
页数:13
相关论文
共 52 条
[1]   Cut-off Scores of a Brief Neuropsychological Battery (NBACE) for Spanish Individual Adults Older than 44 Years Old [J].
Alegret, Montserrat ;
Espinosa, Ana ;
Valero, Sergi ;
Vinyes-Junque, Georgina ;
Ruiz, Agustin ;
Hernandez, Isabel ;
Rosende-Roca, Maitee ;
Mauleon, Ana ;
Becker, James T. ;
Tarraga, Lluis ;
Boada, Merce .
PLOS ONE, 2013, 8 (10)
[2]   PET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research [J].
Bao, Weiqi ;
Xie, Fang ;
Zuo, Chuantao ;
Guan, Yihui ;
Huang, Yiyun Henry .
FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
[3]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[4]  
Brudfors M., 2020, Medical Image Computing and Computer Assisted Intervention-MICCAI 2020, P253, DOI [DOI 10.1007/978-3-030-59716-0, 10.1007/978-3-030-59716-0_25]
[5]   Alzheimer's disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline [J].
Bucci, Marco ;
Chiotis, Konstantinos ;
Nordberg, Agneta .
MOLECULAR PSYCHIATRY, 2021, 26 (10) :5888-5898
[6]   Early detection of amyloid load using 18F-florbetaben PET [J].
Bullich, Santiago ;
Roe-Vellve, Nuria ;
Marquie, Marta ;
Landau, Susan M. ;
Barthel, Henryk ;
Villemagne, Victor L. ;
Sanabria, Angela ;
Tartari, Juan Pablo ;
Sotolongo-Grau, Oscar ;
Dore, Vincent ;
Koglin, Norman ;
Mueller, Andre ;
Perrotin, Audrey ;
Jovalekic, Aleksandar ;
De Santi, Susan ;
Tarraga, Lluis ;
Stephens, Andrew W. ;
Rowe, Christopher C. ;
Sabri, Osama ;
Seibyl, John P. ;
Boada, Merce .
ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
[7]   Overview of tau PET molecular imaging [J].
Cassinelli Petersen, Gabriel ;
Roytman, Michelle ;
Chiang, Gloria C. ;
Li, Yi ;
Gordon, Marc L. ;
Franceschi, Ana M. .
CURRENT OPINION IN NEUROLOGY, 2022, 35 (02) :230-239
[8]   In Vivo Cortical Spreading Pattern of Tau and Amyloid in the Alzheimer Disease Spectrum [J].
Cho, Hanna ;
Choi, Jae Yong ;
Hwang, Mi Song ;
Kim, You Jin ;
Lee, Hye Mi ;
Lee, Hye Sun ;
Lee, Jae Hoon ;
Ryu, Young Hoon ;
Lee, Myung Sik ;
Lyoo, Chul Hyoung .
ANNALS OF NEUROLOGY, 2016, 80 (02) :247-258
[9]   Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundacio ACE Healthy Brain Initiative (FACEHBI) [J].
de Rojas, Itziar ;
Romero, J. ;
Rodriguez-Gomez, O. ;
Pesini, P. ;
Sanabria, A. ;
Perez-Cordon, A. ;
Abdelnour, C. ;
Hernandez, I. ;
Rosende-Roca, M. ;
Mauleon, A. ;
Vargas, L. ;
Alegret, M. ;
Espinosa, A. ;
Ortega, G. ;
Gil, S. ;
Guitart, M. ;
Gailhajanet, A. ;
Santos-Santos, M. A. ;
Moreno-Grau, Sonia ;
Sotolongo-Grau, O. ;
Ruiz, S. ;
Montrreal, L. ;
Martin, E. ;
Peleja, E. ;
Lomena, F. ;
Campos, F. ;
Vivas, A. ;
Gomez-Chiari, M. ;
Tejero, M. A. ;
Gimenez, J. ;
Perez-Grijalba, V. ;
Marquie, G. M. ;
Monte-Rubio, G. ;
Valero, S. ;
Orellana, A. ;
Tarraga, L. ;
Sarasa, M. ;
Ruiz, A. ;
Boada, M. .
ALZHEIMERS RESEARCH & THERAPY, 2018, 10
[10]   A spatially unbiased atlas template of the human cerebellum [J].
Diedrichsen, Jorn .
NEUROIMAGE, 2006, 33 (01) :127-138